Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 867-874

  Dengler, Thomas J ^a   Zimmermann, Rainer ^a   Meyer, Joachim ^a   Sack, Falk U ^a   Girgsdies, Otto ^b   Kübler, Wolfgang E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Chiron Behring GmbH & Co   (Germany)

Author keywords

Heart transplantation; Immunosuppression; Tick borne encephalitis; Vaccination

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; TACROLIMUS; TICK BORNE ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ARTHRALGIA; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; FEMALE; FEVER; GRAFT REJECTION; HEADACHE; HEART TRANSPLANTATION; HEMATOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NAUSEA; PRIORITY JOURNAL; SEROCONVERSION; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VACCINATION; VOMITING;

ADULT; AGED; ANTIBODIES, VIRAL; CYCLOSPORINE; ENCEPHALITIS, TICK-BORNE; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; VIRAL VACCINES;

EID: 0033605097     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00272-2     Document Type: Article

References (28)

1. Carey W., Pimentel R., Westveer M.K., Vogt D., Broughan T. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol. 85:1990;1590-1592.
2. Lefebure A.F., Verpooten G.A., Couttenye M.M., De Broe M.E. Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients. Vaccine. 11:1993;397-399.
3. Wagner D., Wagenbreth I., Stachan-Kunstyr R., Thoma H.A., Hemmerling H.E., Flik J. Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa Gene 3. Clin Invest. 72(5):1994;350-352.
4. Grekas D., Alivanis P., Kiriazopoulou V., Dioudis C., Sioulis A., Derveniotis V., Tourkantonis A. Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol. 31:1993;553-556.
5. Hofmann G. Vektorgebundene Aspekte der Zeckenencephalitis in Europa. Bundesgesundheitsbl. 5:1989;183-189.
6. Roggendorf M. Epidemiology of tick-borne encephalitis virus in Germany. Infection. 24:1996;465-466.
7. Haglund M., Forsgren M., Lindh G., Lindquist L. A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy. Scand J Infect Dis. 28:1996;217-224.
8. Heinz F.X., Kunz C., Fauma H. Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow ultracentrifugation. J Med Virol. 6:1980;213.
9. Kunz C., Heinz F.X., Hofmann H. Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis. J Med Virol. 6:1980;103-109.
10. Klockmann U., Bock H.L., Franke V., Hein B., Reiner G., Hilfenhaus J. Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine. J Biol Stand. 17:1989;331-342.
11. Bock H.L., Klockmann U., Jungst C., Schindel Kunzel F., Theobald K., Zerban R. A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study. Vaccine. 8:1990;22-24.
12. Harabacz I., Bock H., Jungst C., Klockmann U., Praus M., Weber R. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens. Vaccine. 10:1992;145-150.
13. Billingham M.E., Cary N.R., Hammond M.E., Kemnitz J., Marboe C., McCallister H.A., Snovar D.C., Winters G.L., Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 9:1990;587-593.
14. Heinz F.X., Berger R., Tuma W., Kunz C. A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology. 126:1983;525-537.
15. Girgsdies O.E., Rosenkranz G. Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study. Vaccine. 14:1996;1421-1428.
16. Petri W.J. Infections in heart transplant recipients. Clin Inf Dis. 18:1994;141-146.
17. Laufer G., Laczkovics A., Wollenek G., Buxbaum P., Graninger W., Holzinger C., Wolner E. Infectious complications in heart transplant recipients with combined low dose cyclosporine, azathioprine and prednisolone immunosuppression. Transplant Proc. 21:1989;2508-2511.
18. Hofmann H., Kunz C., Heinz F.X., Dippe H. Detectability of IgM antibodies against TBE virus after natural infection and after vaccination. Infection. 11:1983;164-166.
19. Wolf H.M., Pum M., Jager R., Istvan L., Mannhalter J.W., Eibl M.M. Cellular and humoral immune responses in haemophiliacs after vaccination against tick-borne encephalitis. Br J Haematol. 82:1992;374-383.
20. Zielinski C.C., Stuller I., Dorner F., Potzi P., Muller C., Eibl M.M. Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy. Cancer. 58:1986;1648-1652.
21. Avanzini M.A., Carra A.M., Maccario R., Zecca M., Pignatti P., Marconi M., Comoli P., Bonetti F., De Stefano P., Locatelli F. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol. 15:1995;137-144.
22. Rand E.B., McCarthy C.A., Whitington P.F. Measles vaccination after orthotopic liver transplantation. J Pediatr. 123:1993;87-89.
23. Blumberg E.A., Albano C., Pruett T., Isaacs R., Fitzpatrick J., Bergin J., Crump C., Hayden F.G. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis. 22:1996;295-302.
24. Dengler T.J., Strnad N., Zimmermann R., Allers C., Markus B.H., Nessen S.V., Kubler W., Zielen S. Pneumococcal vaccination after heart and liver transplantation. Immune responses in immunosuppressed patients and in healthy controls. Dtsch Med Wochenschr. 121:1996;1519-1525.
25. von Hedenstrom M., Heberle U., Theobald K. Vaccination against tick-borne encephalitis (TBE): influence of simultaneous application of TBE immunoglobulin on seroconversion and rate of adverse events. Vaccine. 13:1995;759-762.
26. Kobashigawa J.A., Warner Stevenson L., Johnson B.L., Moriguchi J.D., Kawata N., Drinkwater D.C., Laks H. Influenza vaccine does not cause rejection after cardiac transplantation. Transplant Proc. 25:1993;2738-2739.
27. Cohen A.D., Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun. 9:1996;699-703.
28. Chalmers A., Scheifele D., Patterson C., Williams D., Weber J., Shuckett R., Teufel A. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol. 21:1994;1203-1206.